Efficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids

NCT01324934 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment became very slow.

Conditions

Renal Transplant Rejection

Interventions

DRUG: ATG-Fresenius S

Sponsor

Neovii Biotech

Collaborators

[object Object]
[object Object]
[object Object]